Biological sex impacts COVID-19 outcomes
- PMID: 32569293
- PMCID: PMC7307725
- DOI: 10.1371/journal.ppat.1008570
Biological sex impacts COVID-19 outcomes
Abstract
The current novel coronavirus disease 2019 (COVID-19) pandemic is revealing profound differences between men and women in disease outcomes worldwide. In the United States, there has been inconsistent reporting and analyses of male-female differences in COVID-19 cases, hospitalizations, and deaths. We seek to raise awareness about the male-biased severe outcomes from COVID-19, highlighting the mechanistic differences including in the expression and activity of angiotensin-converting enzyme 2 (ACE2) as well as in antiviral immunity. We also highlight how sex differences in comorbidities, which can be associated with both age and race, impact male-biased outcomes from COVID-19.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Klein SL, Pekosz A, Passaretti C, Anker M, Olukoya P: Sex, gender and influenza In. Geneva: World Health Organization; 2010: 1–58.
-
- Sex, gender and COVID-19. [cited 2020 Apr 11]. https://globalhealth5050.org/covid19/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
